These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15383639)

  • 21. Recombinant adeno-associated virus-mediated delivery of antisense angiotensin II receptor 1 gene attenuates hypertension development.
    Li XG; Yan JT; Xu XZ; Wang JN; Cheng LM; Wang T; Zuo P; Wang DW
    Acta Pharmacol Sin; 2007 Nov; 28(11):1737-45. PubMed ID: 17959024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
    Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
    Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of polyamines in hypertension induced by angiotensin II.
    Ibrahim J; Schachter M; Hughes AD; Sever PS
    Cardiovasc Res; 1995 Jan; 29(1):50-6. PubMed ID: 7895239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.
    Qi Y; Li H; Shenoy V; Li Q; Wong F; Zhang L; Raizada MK; Sumners C; Katovich MJ
    Exp Physiol; 2012 Jan; 97(1):89-101. PubMed ID: 21967903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.
    Fabris B; Candido R; Bortoletto M; Zentilin L; Sandri M; Fior F; Toffoli B; Stebel M; Bardelli M; Belgrado D; Giacca M; Carretta R
    J Hypertens; 2007 Jul; 25(7):1481-90. PubMed ID: 17563572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of angiotensin converting enzyme and angiotensin II receptor in rabbits with hyperthyroid cardiomyopathy].
    Zhang A; Deng W; Yin YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):712-6. PubMed ID: 18093424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular angiotensin AT2 receptors in hypertension and ageing.
    Widdop RE; Vinh A; Henrion D; Jones ES
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):386-90. PubMed ID: 18307726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy.
    Cingolani E; Ramirez Correa GA; Kizana E; Murata M; Cho HC; Marbán E
    Circ Res; 2007 Jul; 101(2):166-75. PubMed ID: 17556655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts.
    Grobe JL; Der Sarkissian S; Stewart JM; Meszaros JG; Raizada MK; Katovich MJ
    Clin Sci (Lond); 2007 Oct; 113(8):357-64. PubMed ID: 17600530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Tsuruda T; Kato J; Hatakeyama K; Masuyama H; Cao YN; Imamura T; Kitamura K; Asada Y; Eto T
    Cardiovasc Res; 2005 Mar; 65(4):921-9. PubMed ID: 15721873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoproterenol-induced hypertrophied rat hearts: does short-term treatment correspond to long-term treatment?
    Takeshita D; Shimizu J; Kitagawa Y; Yamashita D; Tohne K; Nakajima-Takenaka C; Ito H; Takaki M
    J Physiol Sci; 2008 Jun; 58(3):179-88. PubMed ID: 18462563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA interference targeting the ACE gene reduced blood pressure and improved myocardial remodelling in SHRs.
    He J; Bian Y; Gao F; Li M; Qiu L; Wu W; Zhou H; Liu G; Xiao C
    Clin Sci (Lond); 2009 Feb; 116(3):249-55. PubMed ID: 18605985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertensive effects of central angiotensin II infusion and restraint stress are reduced with age.
    Erdos B; Cudykier I; Woods M; Basgut B; Whidden M; Tawil R; Cardounel AJ; Tümer N
    J Hypertens; 2010 Jun; 28(6):1298-306. PubMed ID: 20308921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
    Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
    Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
    Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.